Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
Contact Dermatitis|January 25, 2024
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre studyLuca Stingeni, Caterina Foti, Fabrizio Guarneri, et al.
Clinical and Experimental Dermatology|November 13, 2023
Safety of omalizumab in chronic urticaria during pregnancy: a real-life studyCataldo Patruno, Fabrizio Guarneri, Eustachio Nettis, et al.
Wiener Medizinische Wochenschrift (1946)|January 16, 2013
Atypical fibroxanthoma-a diagnosis of exclusion!Georgi Tchernev, Michael Tronnier, Julian Ananiev, et al.
Dermatology Practical & Conceptual|December 9, 2024
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective StudyLuigi Gargiulo, Luciano Ibba, Alessandra Narcisi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2022
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
Dermatologic Therapy|October 4, 2019
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observationVito Di Lernia, Luca Bianchi, Cristina Guerriero, et al.
Contact Dermatitis|May 1, 2021
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019Luca Stingeni, Rossella Marietti, Leonardo Bianchi, et al.
The Journal of Dermatological Treatment|April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern ItalyStefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Frontiers in Immunology|January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Italian Journal of Dermatology and Venereology|April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergensLuca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Pageof 22